PDGFRB and chronic myelogenous leukemia, BCR-ABL1 positive: PDGFRB translocation alone appears to be a leukemogenic driver (14), explaining the usual absence of additional mutations or cytogenetic anomalies—similar to BCR::ABL1 in CML.